Regenerative potential of biphasic calcium phosphate and enamel matrix derivatives in the treatment of isolated interproximal intrabony defects: a randomized controlled trial
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The combined use of biomaterials for regeneration may have great biological relevance. This study aimed to compare the regenerative potential of biphasic calcium phosphate (BCP) alone and with growth factor enamel matrix derivatives (EMDs) for the regeneration of intrabony defects at 1 year. Methods: This randomized controlled trial included 40 sites in 29 patients with stage II/III periodontitis and 2/3 wall intrabony defects that were treated with BCP alone (control group) or a combination of BCP and EMD (test group). BCP alloplastic bone grafts provide better bio-absorbability and accelerate bone formation. EMDs are commercially available amelogenins. Mean values and standard deviations were calculated for the following parameters: plaque index (PI), papillary bleeding index (PBI), vertical probing pocket depth (V-PPD), vertical clinical attachment level (V-CAL), and radiographic defect depth (RDD). Student paired and unpaired t-tests were used to compare the data from baseline to 12 months for each group and between the groups, respectively. The results were considered statistically significant at p<0.05. Results: At 12 months, the PI and PBI scores of the control and test groups were not significantly different (p>0.05). The mean V-PPD difference, V-CAL gain, and RDD difference were statistically significant in both groups at 12 months (p<0.001 for all parameters). Intergroup comparisons showed that the mean V-PPD reduction (2.13±1.35 mm), V-CAL gain (2.53±1.2 mm), and RDD fill (1.33±1.0 mm) were statistically significant between the groups at 12 months (p<0.001 for all parameters). Conclusion: BCP and EMDs combination is a promising modality for the regeneration of intrabony defects.
Abstract
Background: The combined use of biomaterials for regeneration may have great biological relevance. This study aimed to compare the regenerative potential of biphasic calcium phosphate (BCP) alone and with growth factor enamel matrix derivatives (EMDs) for the regeneration of intrabony defects at 1 year. Methods: This randomized controlled trial included 40 sites in 29 patients with stage II/III periodontitis and 2/3 wall intrabony defects that were treated with BCP alone (control group) or a combination of BCP and EMD (test group). BCP alloplastic bone grafts provide better bio-absorbability and accelerate bone formation. EMDs are commercially available amelogenins. Mean values and standard deviations were calculated for the following parameters: plaque index (PI), papillary bleeding index (PBI), vertical probing pocket depth (V-PPD), vertical clinical attachment level (V-CAL), and radiographic defect depth (RDD). Student paired and unpaired t-tests were used to compare the data from baseline to 12 months for each group and between the groups, respectively. The results were considered statistically significant at p<0.05. Results: At 12 months, the PI and PBI scores of the control and test groups were not significantly different (p>0.05). The mean V-PPD difference, V-CAL gain, and RDD difference were statistically significant in both groups at 12 months (p<0.001 for all parameters). Intergroup comparisons showed that the mean V-PPD reduction (2.13±1.35 mm), V-CAL gain (2.53±1.2 mm), and RDD fill (1.33±1.0 mm) were statistically significant between the groups at 12 months (p<0.001 for all parameters). Conclusion: BCP and EMDs combination is a promising modality for the regeneration of intrabony defects.
참고문헌 (40)
- Gottlow J, "New attachment formation in the human periodontium by guided tissue regeneration : case reports", J Clin Periodontol, 13, pp.604~616 (1986)
- Rose LF, "Bone grafts and growth and differentiation factors for regenerative therapy : a review", Pract Proced Aesthet Dent, 13, pp.725~734 (2001)
- Tonetti MS, "Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery", J Clin Periodontol, 23, pp.548~556 (1996)
- Froum SJ, "Healing responses of human intraosseous lesions following the use of debridement, grafting and citric acid root treatment. I. Clinical and histologic observations six months postsurgery", J Periodontol, 54, pp.67~76 (1983)
- Barney VC, "Bioceramic implants in surgical periodontal defects : a comparison study", J Periodontol, 57, pp.764~770 (1986)
- Snyder AJ, "Alloplastic implants of tricalcium phosphate ceramic in human periodontal osseous defects", J Periodontol, 55, pp.273~277 (1984)
- Döri F, "Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate", J Periodontol, 76, pp.2236~2243 (2005)
- 김수경, "Evaluating intra- and inter-examiner reproducibility in histometric measurement: onewall intrabony periodontal defects in beagle dogs", Journal of Periodontal & Implant Science, 40(4), pp.172~179 (2010), 대한치주과학회
- Pontoriero R, "The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects : a prospective controlled clinical study", J Clin Periodontol, 26, pp.833~840 (1999)
- Heijl L, "Enamel matrix derivative(EMDOGAIN)in the treatment of intrabony periodontal defects", J Clin Periodontol, 24(9 Pt 2), pp.705~714 (1997)
- Velasquez-Plata D, "Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans", J Periodontol, 73, pp.433~440 (2002)
- Jensen SS, "Evaluation of a novel biphasic calcium phosphate in standardized bone defects : a histologic and histomorphometric study in the mandibles of minipigs", Clin Oral Implants Res, 18, pp.752~760 (2007)
- General Assembly of the World Medical Association, "World Medical Association Declaration of Helsinki : ethical principles for medical research involving human subjects", J Am Coll Dent, 81, pp.14~18 (2014)
- Caton JG, "A new classification scheme for periodontal and peri-implant diseases and conditions: introduction and key changes from the 1999 classification", J Clin Periodontol, 45(Suppl 20), pp.S1~S8 (1999)
- Turesky S, "Reduced plaque formation by the chloromethyl analogue of victamine C", J Periodontol, 41, pp.41~43 (1970)
- Mühlemann HR, "Gingival sulcus bleeding : a leading symptom in initial gingivitis", Helv Odontol Acta, 15, pp.107~113 (1971)
- Shetty S, "A clinical and radiographic evaluation of the management of periodontal osseous defects with alloplast and platelet rich plasma", J Regen Med Tissue Eng, 2, pp.11~ (2013)
- 이민재, "Clinical evaluation of a biphasic calcium phosphate grafting material in the treatment of human periodontal intrabony defects", Journal of Periodontal & Implant Science, 42(4), pp.127~135 (2012), 대한치주과학회[DOI]
- Stein JM, "Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects : a 12-month randomized controlled clinical trial", J Periodontol, 80, pp.1774~1782 (2009)
- Ozdemir B, "Treatment of intrabony defects with beta-tricalciumphosphate alone and in combination with platelet-rich plasma", J Biomed Mater Res B Appl Biomater, 100, pp.976~983 (2012)
- Pietruska M, "Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate", Clin Oral Investig, 16, pp.1191~1197 (2012)
- Francetti L, "Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects : a 24-month multicenter study", Int J Periodontics Restorative Dent, 25, pp.461~473 (2005)
- Parodi R, "Treatment of intrabony pockets with Emdogain : results at 36 months", Int J Periodontics Restorative Dent, 24, pp.57~63 (2004)
- Sculean A, "Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative : report of 26 cases", Int J Periodontics Restorative Dent, 27, pp.221~229 (2007)
- Kaushick BT, "Treatment of human periodontal infrabony defects with hydroxyapatite + β tricalcium phosphate bone graft alone and in combination with platelet rich plasma : a randomized clinical trial", Indian J Dent Res, 22, pp.505~510 (2011)
- Pandit N, "A comparative evaluation of biphasic calcium phosphate material and bioglass in the treatment of periodontal osseous defects : a clinical and radiological study", J Contemp Dent Pract, 11, pp.25~32 (2010)
- Jasser RA, "Effectiveness of beta-tricalcium phosphate in comparison with other materials in treating periodontal infra-bony defects around natural teeth : a systematic review and meta-analysis", BMC Oral Health, 21, pp.219~ (2021)
- Dewi AH, "The use of hydroxyapatite bone substitute grafting for alveolar ridge preservation, sinus augmentation, and periodontal bone defect : a systematic review", Heliyon, 4, pp.e00884~ (2018)
- Cãlin C, "Growth factors and beta-tricalcium phosphate in the treatment of periodontal intraosseous defects : a systematic review and meta-analysis of randomised controlled trials", Arch Oral Biol, 66, pp.44~54 (2016)
- Stavropoulos A, "Regenerative periodontal therapy in intrabony defects and long-term tooth prognosis", Dent Clin North Am, 66, pp.103~109 (2022)
- Vandana KL, "Clinical and radiographic evaluation of Emdogain as a regenerative material in the treatment of interproximal vertical defects in chronic and aggressive periodontitis patients", Int J Periodontics Restorative Dent, 24, pp.185~191 (2004)
- Okuda K, "Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans : a comparative controlled clinical study", J Periodontol, 76, pp.890~898 (2005)
- Stavropoulos A, "Clinical and histologic evaluation of granular beta-tricalcium phosphate for the treatment of human intrabony periodontal defects : a report on five cases", J Periodontol, 81, pp.325~334 (2010)
- Lynch KL, "Bioceramics: volume 3: proceedings of the 3rd International Symposium on Ceramics in Medicine", pp.295~304 (1992), Rose-Hulman Institute of Technology
- Gestrelius S, "Formulation of enamel matrix derivative for surface coating : kinetics and cell colonization", J Clin Periodontol, 24(9 Pt 2), pp.678~684 (1997)
- Van der Pauw MT, "Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts", J Periodontol, 71, pp.31~43 (2000)
- Zetterström O, "Clinical safety of enamel matrix derivative(EMDOGAIN)in the treatment of periodontal defects", J Clin Periodontol, 24(9 Pt 2), pp.697~704 (1997)
- Ellegaard B, "New attachment of periodontal tissues after treatment of intrabony lesions", J Periodontol, 42, pp.648~652 (1971)
- Meyle J, "A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives", synthetic bone graft or enamel matrix derivatives alone : results after 12 months, 2011, pp.38, 652~660
- Schallhorn RG, "Iliac transplants in periodontal therapy", J Periodontol, 41, pp.566~580 (1970)